Cargando…
Adoptive immunotherapy with interleukin-2 & induced killer cells in non-small cell lung cancer: A systematic review & meta-analysis
BACKGROUND & OBJECTIVES: The effectiveness of interleukin-2 (IL-2) and induced killer cells for non-small cell lung cancer (NSCLC) is controversial. This study evaluates the efficacy and safety of interleukin-2 and induced killer cells on NSCLC, so as to provide references for further clinical p...
Autores principales: | Mi, Denghai, Ren, Weiwei, Yang, Kehu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080917/ https://www.ncbi.nlm.nih.gov/pubmed/27748271 http://dx.doi.org/10.4103/0971-5916.191738 |
Ejemplares similares
-
Adoptive Immunotherapy of Cytokine-Induced Killer Cell Therapy in the Treatment of Non-Small Cell Lung Cancer
por: Wang, Min, et al.
Publicado: (2014) -
Meta-Analysis of Neoadjuvant Immunotherapy for Patients with Resectable Non-Small Cell Lung Cancer
por: Cao, Christopher, et al.
Publicado: (2021) -
Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022) -
Adoptive Immunotherapy in Postoperative Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zeng, Yuan, et al.
Publicado: (2016) -
Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
por: Kisseberth, William C., et al.
Publicado: (2021)